Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
10.03
+0.15 (1.52%)
At close: Jun 26, 2026, 4:00 PM EDT
10.30
+0.27 (2.69%)
After-hours: Jun 26, 2026, 7:39 PM EDT
Vir Biotechnology Employees
Vir Biotechnology had 367 employees as of December 31, 2025. The number of employees decreased by 41 or -10.05% compared to the previous year.
Employees
367
Change (1Y)
-41
Growth (1Y)
-10.05%
Revenue / Employee
$178,460
Profits / Employee
-$1,206,313
Market Cap
1.69B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Sarepta Therapeutics | 835 |
| UroGen Pharma | 298 |
| Zymeworks | 243 |
| Innoviva | 159 |
| Absci | 140 |
| AnaptysBio | 104 |
| Bicara Therapeutics | 103 |
VIR News
- 16 days ago - Vir Biotechnology price target raised to $27 from $23 at Morgan Stanley - TheFly
- 16 days ago - Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors - Business Wire
- 4 weeks ago - Vir Biotechnology Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Vir Biotechnology to present complete week 96 data from Phase 2 SOLSTICE trial - TheFly
- 5 weeks ago - Vir Biotechnology to Present Complete Week 96 Data from Phase 2 SOLSTICE Clinical Trial in Hepatitis Delta at the European Association for the Study of the Liver (EASL) Congress 2026 - Business Wire
- 6 weeks ago - Vir Biotechnology Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Vir Biotechnology price target lowered to $23 from $24 at Morgan Stanley - TheFly
- 7 weeks ago - Vir Biotechnology reports Q1 EPS (85c) vs. (88c) last year - TheFly